Submission Details
| 510(k) Number | K043245 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 23, 2004 |
| Decision Date | April 29, 2005 |
| Days to Decision | 157 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K043245 is an FDA 510(k) clearance for the EPS EASY PAIN SUPREME SELF MONITORING BLOOD GLUCOSE SYSTEM, a Glucose Oxidase, Glucose (Class II — Special Controls, product code CGA), submitted by Eps Bio Technology Corp. (Flagstaff, US). The FDA issued a Cleared decision on April 29, 2005, 157 days after receiving the submission on November 23, 2004. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1345.
| 510(k) Number | K043245 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 23, 2004 |
| Decision Date | April 29, 2005 |
| Days to Decision | 157 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CGA — Glucose Oxidase, Glucose |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1345 |